Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Sodium chloride
Drug ID BADD_D02473
Description Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential Medicines.
Indications and Usage This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
Marketing Status approved; vet_approved
ATC Code A12CA01; B05CB01; B05XA03
DrugBank ID DB09153
KEGG ID D02056
MeSH ID D012965
PubChem ID 5234
TTD Drug ID D04YZL
NDC Product Code 76420-083; 80327-011; 82529-000; 10106-3301; 81861-0026; 82056-0001; 24208-277; 42829-001; 46163-300; 51662-1258; 51879-122; 52584-888; 52584-966; 57826-441; 0338-0160; 63323-093; 63323-187; 63323-632; 63323-924; 65219-222; 0409-1141; 69842-284; 0536-1254; 70529-022; 70529-049; 71872-7084; 79672-613; 80762-0010; 81826-001; 24600-1386; 17271-700; 24208-385; 52584-186; 0264-1800; 0264-2201; 0264-5804; 0264-7805; 0338-9151; 65219-472; 65282-1505; 65282-1510; 0404-9953; 69842-285; 70529-136; 70795-1120; 71872-7248; 76297-001; 80762-0012; 24600-1138; 0990-7730; 11822-0470; 49230-300; 0220-3593; 0220-3597; 0220-3599; 54973-4080; 59390-183; 0338-0047; 63323-623; 65219-226; 65219-468; 65219-474; 0404-9955; 68428-885; 70369-007; 70369-010; 54973-6433; 0338-0054; 62106-5206; 63323-090; 63323-186; 0363-5558; 0363-7500; 65219-470; 0409-1966; 0536-1253; 0641-6144; 73666-0580; 77267-007; 80771-000; 0990-7138; 55579-937; 17478-622; 50090-2488; 0220-3598; 51662-1577; 0264-7802; 58264-0135; 0338-0050; 0338-0051; 0338-0182; 0338-0553; 0338-9543; 0363-1505; 63323-088; 64117-867; 65219-220; 65219-230; 65219-232; 0404-9978; 80327-009; 11014-0075; 24874-0001; 49452-6690; 49452-6700; 0990-7983; 11822-0469; 17271-701; 42829-505; 51662-1318; 0264-7800; 0264-9375; 54973-4095; 55681-305; 0338-0186; 0338-0192; 63323-095; 63323-626; 0363-9050; 0409-4888; 0409-7101; 71872-7083; 73666-0550; 73666-0560; 73666-0570; 14639-6444; 70343-210; 70387-109; 11822-5458; 42829-003; 51662-1464; 0264-7806; 55154-4358; 0338-0162; 0338-0166; 63323-530; 65219-466; 0487-4301; 69626-0064; 69842-533; 70529-021; 76328-100; 10695-153; 24208-276; 0220-3586; 0220-3590; 51662-1342; 51879-191; 0264-5802; 55910-632; 0338-0056; 0338-9159; 65219-218; 65219-432; 67091-327; 70529-024; 71309-154; 0641-0497; 76472-1154; 76472-4096; 77333-835; 77333-844; 0990-6138; 51552-0077; 0990-7972; 0990-7985; 55154-9357; 0338-0048; 0338-0049; 59779-303; 63323-099; 0363-5557; 65219-224; 65219-228; 68428-061; 69842-473; 70529-023; 71872-7082; 0641-1512; 76472-4026; 80762-0011; 10106-3302; 24600-1382; 63822-0001; 51662-1522; 0363-0193; 62106-1058; 63323-139; 64253-202; 0404-9954; 68428-111; 68428-526; 0409-6660; 69842-472; 0990-7984; 69500-110; 70387-115; 17478-623; 42829-407; 42829-504; 49281-912; 0019-1188; 0220-3595; 0220-3600; 52584-109; 55154-0126; 58657-118; 0338-0043; 0338-0164; 0338-0196
UNII 451W47IQ8X
Synonyms Sodium Chloride | Sodium Chloride, (22)Na | Sodium Chloride, (24)NaCl
Chemical Information
Molecular Formula ClNa
CAS Registry Number 7647-14-5
SMILES [Na+].[Cl-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Systemic inflammatory response syndrome24.06.03.008; 10.02.01.008; 08.01.05.0050.000241%Not Available
Injection site discolouration23.03.03.046; 12.07.03.038; 08.02.03.0380.000821%Not Available
Conjunctival hyperaemia06.04.01.0040.000362%Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Inappropriate antidiuretic hormone secretion14.05.07.001; 05.03.03.0010.000531%Not Available
Skin swelling23.03.03.0390.000241%Not Available
Injection site swelling12.07.03.018; 08.02.03.0170.001183%Not Available
Infusion site pain12.07.05.002; 08.02.05.0140.000531%Not Available
Type IV hypersensitivity reaction10.01.03.0220.000241%Not Available
Injection site discomfort08.02.03.018; 12.07.03.019--Not Available
Haemorrhagic transformation stroke24.07.04.018; 17.08.01.0360.000241%Not Available
Haemorrhage24.07.01.0020.001569%Not Available
Fluid intake reduced14.05.10.001--Not Available
Gaze palsy17.02.05.044; 06.05.02.0140.000241%Not Available
Temperature intolerance08.01.09.0220.003983%Not Available
Hypoaesthesia oral17.02.06.021; 07.05.05.0030.000362%Not Available
Breast cancer female21.05.01.011; 16.10.01.004--Not Available
Bipolar disorder19.16.01.003--Not Available
Cognitive disorder19.21.02.001; 17.03.03.003--
Injection site nodule23.07.04.009; 12.07.03.034; 08.02.03.034--Not Available
Metabolic disorder14.11.01.0010.000241%Not Available
Pulseless electrical activity02.03.04.0200.000241%Not Available
Lung neoplasm malignant22.08.01.001; 16.19.02.001--Not Available
Cerebrovascular insufficiency17.08.02.003; 24.04.06.004--Not Available
Injection site scar23.03.11.016; 12.07.03.050; 08.02.03.050--Not Available
Metastases to central nervous system17.02.10.013; 16.22.02.004--Not Available
Infusion site rash23.03.13.018; 12.07.05.017; 08.02.05.0170.000241%Not Available
Neurological symptom17.02.05.0100.000362%Not Available
Adverse event08.06.01.010--Not Available
Appetite disorder19.09.01.002; 14.03.01.0040.000241%Not Available
The 14th Page    First    Pre   14 15 16 17    Next   Last    Total 17 Pages